ARTICLE
8 April 2025

Regulatory Compliance In The Food And Healthcare Industry In Nigeria And Kenya

Gresyndale Legal

Contributor

Gresyndale International is a corporate law firm that helps international entities come into West African countries and function effectively, especially in Nigeria and Kenya. Our subsidiary, Gresyndale Legal, offers premier legal advisory services to businesses worldwide. Our team of dedicated and exceptional lawyers provides top-notch services in various areas of law.
The work discusses regulatory compliance in the food and healthcare industries as being critical to ensuring public safety, product quality and consumer protection.
Nigeria Food, Drugs, Healthcare, Life Sciences

Abstract

The work discusses regulatory compliance in the food and healthcare industries as being critical to ensuring public safety, product quality and consumer protection. Thus, due to the complex nature of these industries in Nigeria and Kenya, there have been various challenges and obstacles faced by these organizations which have been outlined to help achieve best practices in regulatory compliance in Nigeria and Kenya's food and healthcare industries.

Introduction

Food and healthcare sectors are extremely important sectors of the economy in many countries. Various government agencies have enacted written laws for compliance to prevent potential harm and violations by operators in these sectors.1 However, the need for regulation must also be balanced with the costs of the regulation to the public, producers, and the economy as a whole. It is viewed as necessary and inevitable in the Western world, regulations can be seen as a very frustrating constraint in many other parts of the world. After years of economic crisis, regulations in many developing countries, particularly in Africa, have taken the form of simple protectionism and import substitution. Compliance is not a one-size-fits-all issue, but rather, it should be based on a sound understanding of the entire regulatory environment and best practices within the framework of the country or market. This is evidenced by Nigeria and Kenya, both increasing their effectiveness. Regulating the healthcare market is generally desirable.2 The regulation should facilitate access to information about services and professional qualifications, thereby reducing informational asymmetries between provider and consumer. Regulatory bodies may enforce a healthy market to carry out services that guarantee quality, probity, and fairness. Many countries have taken legal and sometimes even constitutional steps to regulate certain aspects of private health care. On the healthcare provider side, this includes licensing procedures to filter out the incompetent, unsuitable, and potentially dangerous, disciplinary regulations to monitor professional conduct, and medico-legal rules pertaining to the relationship between providers and patients. On the producer side, enforcing monopoly power or cartelization is often employed via price ceilings, which have been used to control fees and charge rates.

Regulatory Frameworks in Nigeria and Kenya

The food and healthcare sectors are vital in Nigeria and Kenya, necessitating rigorous regulatory frameworks to guarantee the safety, efficacy, and quality of products and services. These frameworks are built around national statutory laws, acts, and international guidelines that emphasize consumer protection and the maintenance of public health. This discussion provides an overview of the regulatory frameworks governing compliance in these industries within Nigeria and Kenya, highlighting relevant statutory laws, acts, and the role of regulatory bodies.

Nigeria:

1. Food Industry Regulatory Framework

Nigeria's food industry is regulated primarily by the National Agency for Food and Drug Administration and Control (NAFDAC) and the Standards Organisation of Nigeria (SON).

NAFDAC: Established under the NAFDAC Act Cap N1 LFN 2004, this agency is the primary regulatory responsible for regulating and controlling the manufacture, importation, exportation, distribution, advertisement, and use of food, drugs, cosmetics, medical devices, and chemicals. NAFDAC ensures compliance with food safety standards and conducts inspections and laboratory testing to prevent the circulation of substandard or counterfeit products (NAFDAC, 2004). The agency issues guidelines to manufacturers, importers, and distributors regarding the processes of registration, inspection, and quality control for food and healthcare products under the NAFDAC Guideline.

NAFDAC works with various regulatory agencies, including:

SON: The Standards Organisation of Nigeria Act No. 14 of 2015 empowers SON to set and enforce standards for all products, including food. SON works to ensure that food products meet both national and international quality standards (SON Act, 2015).

2. Regulatory Framework of the Healthcare Industry

The healthcare sector in Nigeria is regulated by several bodies, including the Federal Ministry of Health (FMOH), NAFDAC, and the Pharmacists Council of Nigeria (PCN).

NAFDAC: In addition to food regulation, NAFDAC oversees the safety and efficacy of pharmaceuticals, medical devices, and vaccines. It ensures compliance with Good Manufacturing Practices (GMP) and conducts post-market surveillance.

PCN: The Pharmacists Council of Nigeria Act Cap P17 LFN 2004 regulates the practice of pharmacy and ensures that medicines meet quality standards and that healthcare providers comply with professional practice regulations.

National Health Act (2014): Provides a framework for the regulation, development, and management of the national health system in Nigeria. It emphasizes quality assurance and patient safety.

Environmental Health Officers Registration Council of Nigeria (EHORECON): This council is responsible for regulating environmental health practices, including sanitation in the food and healthcare sectors, under the EHORECON Act 2002.

Relevant Legislation

Food, Drugs, and Related Products (Registration) Act Cap F33 LFN 2004: Governs the registration of food products.

Consumer Protection Act 2019: The law establishes the Federal Competition and Consumer Protection Commission (FCCPC), responsible for safeguarding consumers against exploitative and unsafe practices.

Public Health Act Cap P42 LFN 2004: Addresses public health concerns related to food safety.

KENYA

1. Regulatory Framework for the Food Industry

The Kenya Bureau of Standards (KEBS) and the Public Health Act regulate Kenya's food industry. KEBS: Established under the Standards Act Cap 496 of the Laws of Kenya; KEBS is the national standard body in charge of developing and enforcing food product standards. It guarantees adherence to East African Standards (EAS) and international standards such as Codex Alimentarius (Standards Act, 2012).

Public Health Act, Section 242: This act establishes the legal framework for food safety and hygiene. It enables public health officers to inspect food establishments and enforce food safety regulations.

Other relevant laws:

2. Regulatory Framework for the Healthcare Industry.

The Kenya Medical Practitioners and Dentists Council (KMPDC), the Pharmacy and Poisons Board (PPB), and the Ministry of Health all oversee the country's healthcare system.

PPB: The PPB was established under the Pharmacy and Poisons Act Cap 244 to regulate medicine manufacturing, distribution, and dispensing. It ensures compliance with Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP).

KMPDC: The Medical Practitioners and Dentists Act Cap 253 governs the registration and licensing of medical practitioners and dentists, ensuring they adhere to professional standards.

The Health Act (2017) establishes a comprehensive framework for the regulation of healthcare services, covering quality assurance, patient rights, and public health.

Relevant

The Food, Drugs, and Chemical Substances Act Cap 254 governs the production, importation, and sale of food, drugs, and chemical substances.

The Agriculture and Food Authority Act (2013) creates the Agriculture and Food Authority (AFA) to regulate and develop the food industry.

The Narcotic Drugs and Psychotropic Substances (Control) Act (1994) governs the use of controlled substances in healthcare.

The Medical Supplies Authority Act (2019) establishes the Kenya Medical Supplies Authority (KEMSA) to ensure the availability of high-quality medical products.

Comparative Analysis of Nigeria

Comparison Analysis

While Kenya and Nigeria have both strengthened their regulatory frameworks significantly, their strategies and results differ noticeably. In Nigeria, NAFDAC plays a central role and serves as the primary regulatory body responsible for regulating the food and healthcare industries. Its regulatory framework is supplemented by several laws, including the Food and Drugs Act and the Consumer Protection Act. NAFDAC strives to ensure compliance with both national and international standards, particularly the Codex Alimentarius for food safety and the World Health Organisation (WHO) guidelines for healthcare while in Kenya, Kenya's regulatory environment is slightly more decentralised, with various agencies such as KEBS, PPB, and NFSCC playing important roles. The coordination of these agencies ensures that food and healthcare products meet safety and quality requirements. The Consumer Protection Act strengthens Kenya's regulatory framework by ensuring consumer rights are upheld in both industries.

However, Kenya's regulatory framework is more centralized under the Ministry of Health, while Nigeria's framework involves multiple agencies with overlapping mandates. Both countries face challenges in enforcement due to limited resources, corruption, and the proliferation of counterfeit products.

Challenges and Best Practices in Achieving Regulatory Compliance

Challenges:

i. Lack of Adequate Infrastructure and Resources

Nigeria and Kenya encounter substantial infrastructural obstacles that impede effective regulation and compliance. Regulatory bodies such as the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria and the Kenya Bureau of Standards (KEBS) struggle with inadequate laboratories, testing facilities, and monitoring tools, resulting in delays in product approvals and enforcement of regulations.

Nigeria: Many companies in the healthcare and food industries experience delays in product registration and certification due to a lack of adequate testing laboratories, which causes bottlenecks in regulatory processes.

Kenya: KEBS and other regulatory bodies, such as the Pharmacy and Poisons Board (PPB), also face challenges in ensuring timely inspections and certifications, which affects compliance efforts (Oyaro, 2020).

ii. Limited Awareness and Training on Regulatory Requirements

Insufficient knowledge and awareness among industry stakeholders is a prevalent issue in both nations. Small and medium-sized enterprises (SMEs) in the food and healthcare industries may lack the necessary information on regulatory standards, registration processes, and compliance procedures.

Nigeria: Many local manufacturers and distributors are unaware of the full scope of NAFDAC's regulations, leading to non-compliance (Odili et al., 2021).3

Kenya: A similar challenge exists in Kenya, where businesses, particularly in rural areas, are not fully informed about the food safety regulations set by KEBS and other regulatory authorities (Wambugu, 2020). 4

iii. Corruption and Regulatory Lapses

Corruption in regulatory agencies can obstruct enforcement and compliance. Bribery and the manipulation of regulatory processes often compromise the integrity of regulatory frameworks, allowing non-compliant products to enter the market.

Nigeria: Corruption within some agencies has been cited as a major impediment to ensuring regulatory compliance in the healthcare and food sectors.

Kenya: Reports of regulatory officers being bribed to approve substandard products are prevalent, which undermines public trust in the regulatory process.

iv. Counterfeit Products and Substandard Goods

The ubiquity of counterfeit goods in both nations presents a considerable obstacle to regulatory adherence. Counterfeit food and pharmaceuticals not only endanger public health but also undermine the effectiveness of regulatory frameworks.

Nigeria: NAFDAC has had to deal with a high incidence of counterfeit drugs, which has been linked to inefficiencies in product tracking and monitoring systems (NAFDAC, 2021).

Kenya: The Pharmacy and Poisons Board has noted an increase in counterfeit and substandard pharmaceutical products, which is exacerbated by porous borders and inadequate enforcement of regulations (PPB, 2020).

v. Inconsistence Enforcement and Bureaucratic Delays

Discrepancies in regulatory enforcement and bureaucratic delays are prevalent challenges. Regulatory agencies may lack the capacity or will to enforce compliance uniformly across the board, leading to selective enforcement.

Nigeria: Bureaucratic delays in NAFDAC's processes sometimes lead to long wait times for product registration and certification, discouraging full compliance from industry players (NAFDAC, 2022).

Kenya: The PPB and KEBS face similar issues, with delays in inspections and enforcement affecting compliance, particularly in the pharmaceutical industry (Wambugu, 2020).5

Best Practices

i. Public Awareness and Capacity Building

Regulatory authorities must implement awareness campaigns and offer training programs to inform industry participants about compliance obligations. This helps ensure that businesses, particularly SMEs, are informed and prepared to meet regulatory standards.

Nigeria: NAFDAC has initiated training and sensitization workshops for SMEs on product registration and compliance, which has led to an improved understanding of regulatory processes (Odili et al., 2021).6

Kenya: The Pharmacy and Poisons Board has been involved in capacity-building initiatives targeting pharmacists and manufacturers, particularly in rural areas, to promote compliance with drug safety regulations (PPB, 2020).

ii. Use of Technology for Product Tracking and Monitoring

The distribution of counterfeit or inferior products can be avoided by using technology to track and monitor products throughout the supply chain. For instance, blockchain technology can offer supply chain traceability and transparency, which makes it simpler to identify and eliminate non-compliant goods.

Nigeria: To improve pharmaceutical product traceability and lower the prevalence of counterfeit medication, NAFDAC has started investigating the application of blockchain technology (NAFDAC, 2021).

Kenya: To make sure that only approved products make it to market, KEBS is collaborating with partners in the private sector to create a digital system for tracking food products through the supply chain (Wambugu, 2020).

iii. Collaboration with Internation Regulatory Bodies

Working together with international organizations like the Food and Agriculture Organization (FAO) and the World Health Organization (WHO) helps bring national laws into line with best practices from around the world. This guarantees that industry participants are following the most recent standards and that regulatory frameworks are updated.

Nigeria: To improve the overall quality of healthcare products, NAFDAC works with the WHO to make sure that its regulations match international standards (NAFDAC, 2022).

Kenya: To ensure that pharmaceutical products fulfil international safety standards, the PPB has collaborated with the WHO to implement Good Manufacturing Practices (GMP) standards (PPB, 2020).

iv. Strengthening Institutional Capacity

It is essential to increase regulatory bodies' capacity through better staffing, infrastructure, and technology. To fill in infrastructure gaps and guarantee prompt enforcement of regulations, investments should be made in state-of-the-art testing facilities, monitoring systems, and inspection instruments.

Nigeria: To expedite the registration of food and healthcare products, NAFDAC implemented the NAFDAC Automated Product Administration and Monitoring System (NAPAMS), which decreases delays and improves transparency (NAFDAC, 2022).

Kenya: By following predetermined quality standards, manufacturers can expedite the certification process through the KEBS Product Mark Scheme, which was introduced by KEBS (KEBS, 2021).

Impact of Regulatory Compliance on the Food and Healthcare Industry

  1. Positive Impacts
    1. Improved Public Health and Safety: Regulatory compliance has led to significant improvements in public health outcomes in both countries. For example, NAFDAC's efforts in Nigeria have reduced the prevalence of counterfeit drugs, and KEBS' enforcement of food safety standards in Kenya has reduced foodborne illnesses. 7
    2. Increased Consumer Confidence: Adherence to regulatory standards has improved consumer trust in food and healthcare products. In Kenya, adherence to international food safety standards has increased horticultural product exports, contributing to economic growth (Kariuki et al.2018).8
  2. Challenges in Regulatory Compliance
    1. High Costs for SMEs: Small and medium-sized businesses (SMEs) frequently face the financial burden of compliance. In Nigeria, small-scale food producers may find laboratory testing and certification prohibitively expensive.9 Similarly, in Kenya, SMEs struggle to meet the complex requirements of regulatory agencies (Mugambi et al., 2019).10
    2. Regulatory Bottlenecks: Protracted approval processes and bureaucratic inefficiencies can cause delays in the introduction of new products. The drug registration process in Nigeria has been criticized for limiting access to essential medicines (Auta et al., 2017).11

5. Future Trends and Recommendations

  1. Capacity Building: To enhance enforcement and cut down on bureaucratic inefficiencies, regulatory bodies should spend money on training and capacity building.
  2. Public-Private Partnerships: Working together, industry stakeholders and regulatory bodies can tackle issues like resource constraints and high compliance costs.
  3. Technology Integration: Employing digital technologies like blockchain and AI can improve regulatory processes' traceability and transparency.
  4. Harmonisation of Standards: To promote trade and enhance public health outcomes, both nations should endeavour to align their regulatory standards with global norms.

References

  • National Agency for Food and Drug Administration and Control (NAFDAC). (2021). NAFDAC Annual Report 2021.
  • Pharmacy and Poisons Board (PPB). (2020). Annual Report 2020.
  • Wambugu, A. (2020). Food Safety Regulations and Compliance in Kenya. Journal of Food Safety, 15(3), 45-56.
  • Oyaro, K. (2020). Counterfeit Pharmaceuticals in Kenya: A Regulatory Perspective. African Journal of Pharmacy, 12(4), 122-135.
  • Transparency International. (2021). Corruption in Kenya's Public Health Sector: Bribery in Drug Certification.
  • Transparency International. (2022). Corruption in Nigeria's Food and Drug Regulatory Bodies.
  • Odili, V. U., et al. (2021). Regulatory Compliance in Nigeria's Pharmaceutical Industry: Challenges and Prospects. Journal of Regulatory Affairs, 10(1), 19-31.
  • Akinola, A. G., Adeyemo, R., & Oluwatayo, I. B. (2021). Regulatory Compliance and Agricultural Export Performance in Nigeria. Journal of Agricultural Economics and Rural Development, 7(2), 45-56.
  • Auta, A., Maz, J., & Ogbonna, B. O. (2017). Regulatory Challenges in Access to Medicines in Nigeria: A Review. Journal of Pharmaceutical Policy and Practice, 10(1), 1-8.
  • Ezeani, M., Ogbonna, B. O., & Onwujekwe, O. E. (2018). Regulatory Frameworks for Clinical Trials in Nigeria: Challenges and Opportunities. Nigerian Journal of Clinical Practice, 21(3), 267-273.
  • Kariuki, S., Wanyoike, D., & Mwangi, J. (2018). Challenges Facing SMEs in Complying with Food Safety Regulations in Kenya. African Journal of Business Management, 12(4), 78-85.
  • Kenya Bureau of Standards (KEBS). (2020). Food Safety Standards and Regulations in Kenya.
  • Mugambi, M. L., Gitau, L. N., & Nyamai, D. (2019). Regulatory Bottlenecks in the Kenyan Healthcare Sector. East African Medical Journal, 96(5), 123-130.
  • National Agency for Food and Drug Administration and Control (NAFDAC). (2021). Regulatory Guidelines for Food and Drug Administration in Nigeria.
  • Okello, J. J., Narrod, C., & Roy, D. (2020). Food Safety Standards and Export Performance: Evidence from Kenya. Food Policy, 95, 101-112.
  • Olayemi, F. F., Ojo, M. A., & Adebayo, O. (2019). Challenges of Regulatory Compliance for SMEs in the Nigerian Food Industry. Journal of Small Business and Entrepreneurship Development, 7(1), 34-42.
  • Pharmacy and Poisons Board (PPB). (2020). Guidelines for Drug Registration in Kenya.

Footnotes

1. Jagun, C. (2018). Strategies for Compliance with Government Regulations in a Pharmaceutical Company.

2. F. Wafula, C. Molyneux, M. Mackintosh, & C. Goodman (2013). "Protecting the public or setting the bar too high? Understanding the causes and consequences of regulatory actions of front-line regulators and specialized drug shop operators in Kenya".

3. V. U. Odili et al. (2021). Regulatory Compliance in Nigeria's Pharmaceutical Industry: Challenges and Prospects. Journal of Regulatory Affairs, 10(1), 19-31.

4. A. Wambugu (2020). Food Safety Regulations and Compliance in Kenya. Journal of Food Safety, 15(3), 45-56.

5.

6. Supra note 3

7. F.F. Olayemi, M. A. Ojo., & O. Adebayo, (2019). Challenges of Regulatory Compliance for SMEs in the Nigerian Food Industry. Journal of Small Business and Entrepreneurship Development, 7(1), 34-42; J.J. Okello, C. Narrod, & D. Roy, (2020). Food Safety Standards and Export Performance: Evidence from Kenya. Food Policy, 95, 101-112.

8. S. Kariuki, D. Wanyoike, & J. Mwangi, (2018). Challenges Facing SMEs in Complying with Food Safety Regulations in Kenya. African Journal of Business Management, 12(4), 78-85.

9. A. G. Akinola., R. Adeyemo, & I. B Oluwatayo, (2021). Regulatory Compliance and Agricultural Export Performance in Nigeria. Journal of Agricultural Economics and Rural Development, 7(2), 45-56.

10. M. L. Mugambi, Gitau, L. N., & Nyamai, D. (2019). Regulatory Bottlenecks in the Kenyan Healthcare Sector. East African Medical Journal, 96(5), 123-130.

11. . A. Auta, J. Maz, & B. O. Ogbonna, (2017). Regulatory Challenges in Access to Medicines in Nigeria: A Review. Journal of Pharmaceutical Policy and Practice, 10(1), 1-8.

www.Gresyndale.com/blog/

https://www.linkedin.com/company/gresyndale-legal/

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More